Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir

This study aims to understand how the body processes a combined pill containing Bemnifosbuvir (BEM) and Ruzasvir (RZR), and how food affects its absorption. "Bioavailability" is a term that refers to how well the drug enters the bloodstream and reaches where it needs to work. Participants should be healthy adults, weighing at least 50 kg, and agree to use two forms of birth control during the study and for 90 days afterwards. They must also be willing to follow all study instructions and sign a consent form. Those with certain infections like hepatitis or HIV, or those who abuse drugs or alcohol, cannot participate. Participants must not have used other experimental drugs recently or take certain medications.

• The study involves multiple visits over a period of time.
• Participants will undergo tests and monitoring.
• Potential risks are involved, and these will be explained during the consent process.